W
William W. Busse
Researcher at University of Wisconsin-Madison
Publications - 740
Citations - 62685
William W. Busse is an academic researcher from University of Wisconsin-Madison. The author has contributed to research in topics: Asthma & Eosinophil. The author has an hindex of 115, co-authored 697 publications receiving 56703 citations. Previous affiliations of William W. Busse include National Institutes of Health & University at Buffalo.
Papers
More filters
Journal ArticleDOI
P55: patient satisfaction and sensory attributes of two combination nasal sprays (olopatadine hydrochloride/mometasone furoate monohydrate and azelastine hydrochloride/fluticasone propionate) for treatment of allergic rhinitis in australia
Ian D. Pavord,Guy Brusselle,Klaus F. Rabe,Andrew Menzies-Gow,Jana Moody,Arman Altincatal,Nami,Pandit-Abid,David J. Lederer,Yi Zhang,Paul Rowe,Yamo,Deniz,Amr Radwan,Juby A. Jacob-Nara,William W. Busse,Katherine Young,Claire R. Morgan,Vineet,Aggarwal,Dhammraj M Borade,R.H. Gordonsmith +21 more
TL;DR: The results confirmed that higher spIgE to rPas n 1 and rCyn d 1 fluorescence were detected in the grass-pollen allergic patients with clinician diagnosed allergic rhinitis than participants with other allergies or no allergies.
Journal ArticleDOI
Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization
Jonathan Corren,David A. Jackson,Thomas B. Casale,Larry Borish,Klaus F. Rabe,William W. Busse,Jorge Maspero,Daniel J. Jackson,Nadia Daizadeh,Arman Altincatal,Amr Radwan,A. Khodzhayev,Michel Djandji,Juby A. Jacob-Nara,Paul Rowe,Yamo Deniz +15 more
TL;DR: In this article , dupilumab vs placebo significantly reduced asthma exacerbation rates (AER) and improved pre-bronchodilator forced expiratory volume in 1 second (FEV1) in patients with uncontrolled, moderate-to-severe asthma.
Journal ArticleDOI
Digital health in difficult-to-treat severe asthma.
TL;DR: Seneviratne et al. as mentioned in this paper used wearable data to guide the management of uncontrolled asthma in a multicentre, single-blinded, randomised clinical trial.
Journal ArticleDOI
Impact of asthma on the brain: evidence from diffusion MRI, CSF biomarkers and cognitive decline
Ajay Kumar Nair,Carol A. Van Hulle,Barbara B. Bendlin,Henrik Zetterberg,Kaj Blennow,Norbert Wild,Gwendlyn Kollmorgen,Ivonne Suridjan,William W. Busse,Douglas C. Dean,Melissa A. Rosenkranz +10 more
TL;DR: In this paper , the influence of asthma, a highly prevalent chronic inflammatory disease of the airways, on brain health in participants recruited to the Wisconsin Alzheimer's Disease Research Center (31 asthma patients, 186 non-asthma controls, aged 45 to 90 years, 62.2% female, 92.2 % cognitively unimpaired), was determined using detailed prescription information.
Agarwal, Yasha; Matt, Stephaniea; Mompho, Krisnaa; Runner, Kaitlyna; Gaskill, Peter Ja (1) Mediators of inflammation alter HIV latency and re-activation in a human microglial cell line
Rachel Hoel,Henrik Zetterberg,Amanda Heslegrave,Barbara B. Bendlin,Richard S. Davidson,William W. Busse,Melissa A. Rosenkranz +6 more
TL;DR: The in vitro effects of proinflammatory mediators, dopamine, and antiretroviral drugs on HIV latency in an immortalized microglial cell line, HC69, are examined, consistent with previous findings that higher levels of D2 receptors are associated with anti-inflammatory effects in microglia.